Treatment of glenohumeral sepsis with a commercially produced antibiotic-impregnated cement spacer

• Published in: Journal of shoulder and elbow surgery Vol. 19; no. 6; pp. 868 - 873
• Main Authors: Coffey, Michael J., MD, Ely, Erin E., BA, Crosby, Lynn A., MD
• Format: Journal Article
• Language: English
• Published: New York, NY Mosby, Inc 01.09.2010; Elsevier
• Subjects: Aged; Aged, 80 and over; Anti-Bacterial Agents - administration & dosage; Antibacterial agents; antibiotic cement spacer; Antibiotics. Antiinfectious agents. Antiparasitic agents; Arthroplasty, Replacement - adverse effects; Biological and medical sciences; Bone Cements; Coated Materials, Biocompatible; Diseases of the osteoarticular system; Female; Follow-Up Studies; Glenohumeral sepsis; Humans; Male; Medical sciences; Middle Aged; Orthopedics; Pharmacology. Drug treatments; Prosthesis-Related Infections - drug therapy; Prosthesis-Related Infections - surgery; Retrospective Studies; Sepsis - drug therapy; Sepsis - surgery; Shoulder Joint; Staphylococcal Infections - drug therapy; Staphylococcal Infections - microbiology; Staphylococcal Infections - surgery; Staphylococcus aureus - isolation & purification; total shoulder arthroplasty; Treatment Outcome; Treatment Study; Level IV; Glenohumeral sepsis; total shoulder arthroplasty; Case Series; antibiotic cement spacer; Infection; Sepsis syndrome; Antibiotic; Treatment; Glenohumeral joint; Spacer; Shoulder; Cement; Rheumatology; Antibacterial agent

Background We report our experience in treating infected shoulder arthroplasty and primary shoulder sepsis using a commercially produced antibiotic-impregnated cement spacer. Materials and methods We treated 16 shoulders in 15 patients for infected arthroplasty or osteomyelitis of the proximal humer...